Universe Pharmaceuticals (UPC) Total Liabilities (2020 - 2025)

Universe Pharmaceuticals has disclosed Total Liabilities across 6 years of filings, most recently posting $13.2 billion for Q3 2025.

• Total Liabilities for Q3 2025 came in at $13.2 billion, down 41.32% year-over-year; the trailing twelve-month figure through Sep 2025 was $13.2 billion (down 41.32% YoY), and the FY2025 annual result was $13.2 billion, down 41.32% from the prior year.
• Total Liabilities came in at $13.2 billion for Q3 2025 at Universe Pharmaceuticals, down from $22.5 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $22.5 billion in Q3 2024 to a low of -$35.3 billion in Q3 2022.
• The 5-year median for Total Liabilities is $22.9 million (2021), against an average of $68.8 million.
• Across the five-year window, Total Liabilities plunged 152442.21% in 2022 and jumped 163124.63% in 2024, its largest moves.
• Universe Pharmaceuticals' Total Liabilities stood at $23.2 million in 2021, then slumped by 152442.21% to -$35.3 billion in 2022, then jumped by 100.04% to $13.8 million in 2023, then surged by 163124.63% to $22.5 billion in 2024, then slumped by 41.32% to $13.2 billion in 2025.
• The last three Total Liabilities figures came in at $13.2 billion (Q3 2025), $22.5 billion (Q3 2024), and $22.7 million (Q1 2024), per Business Quant data.